TGA
TGA issues Bull Blood warning
Imported “male enhancement supplement” poses safety risk to patients, regulator warns Consumers using a supplement branded as Bull Blood tablets are being urged to stop taking it and hand over …
Tobacco beetles found in constipation supplement
TGA announces recall of two batches of a supplement used to relieve constipation Phytologic Holdings is recalling two batches of Henry Blooms Herb-a-lax 200 gram dried herb powder, after insects …
TGA continues clampdown on nicotine vape advertising
Regulator issues fines totalling more than $150,000 to a company and its director over alleged unlawful advertising of nicotine vapes The Therapeutic Goods Administration (TGA) has fined Kilpatrick & Douglas …
No more nicotine advertising
Government repeals legislation authorising pharmacies to advertise the availability of prescription nicotine Community pharmacies are no longer allowed to promote prescription nicotine products, following the repeal of the Therapeutic Goods …
Further Vyvanse shortages forecast
Takeda Pharmaceuticals Australia warns that a fourth strength of its ADHD medication, Vyvanse, will be in short supply Worldwide shortages of Takeda’s Vyvanse (lisdexamfetamine dimesilate) products are expected to …
Potentially hazardous sports supplements seized
TGA seizes close to 500 sports supplements containing potentially dangerous substances during raid Sports supplements containing a range of prescription and prohibited substances have been seized by authorities following a …
TGA flags compounded Ozempic safety concerns
Pharmacists are being warned that they could be liable for any adverse outcome patients experience should they supply compounded semaglutide-like products Reports that a telehealth provider plans to make compounded …
Do not take ‘Ying Da Wang’ – TGA
Regulator warns Australians to stop taking three medications containing undeclared amounts of sildenafil Safety advisory notices have been issued by the Therapeutic Goods Administration (TGA) in relation to three products …
Fluoxetine update
The TGA has made a Serious Scarcity Substitution Instrument regarding fluoxetine 20mg dispersible tablets To help manage the shortage of the dispersible tablet form of this dose, the Therapeutic Goods …
TGA acts on alleged unlawful advertising
Regulator pursues Federal Court action against CDA Clinics Qld Pty Ltd and its former director in relation to alleged unlawful promotion of medicinal cannabis The Therapeutic Goods Administration (TGA) has …
Oral morphine arrangements
Two new temporary PBS listings for morphine sulfate will be effective from 1 December 2023 The Therapeutic Goods Administration says that these new products are being listed to address the …
Supply shortages continue to challenge pharmacies
Pharmacy staff are being forced to deal with medicines shortages, with 60-day dispensing not making life any easier, pharmacist warns Suggestions from Department of Health and Aged Care bureaucrats, that …